Invention Grant
US08178504B2 Gene therapy expression of GHRH for increasing RBC count in subjects
有权
基因治疗GHRH表达增加受试者的RBC计数
- Patent Title: Gene therapy expression of GHRH for increasing RBC count in subjects
- Patent Title (中): 基因治疗GHRH表达增加受试者的RBC计数
-
Application No.: US11726291Application Date: 2007-03-21
-
Publication No.: US08178504B2Publication Date: 2012-05-15
- Inventor: Ruxandra Draghia-Akli , Robert H. Carpenter , Douglas R. Kern , Robert J. Schwartz , Glen King , Kevin Hahn , Malcolm K. Brenner
- Applicant: Ruxandra Draghia-Akli , Robert H. Carpenter , Douglas R. Kern , Robert J. Schwartz , Glen King , Kevin Hahn , Malcolm K. Brenner
- Applicant Address: US PA Blue Bell
- Assignee: VGX Pharmaceuticals, Inc.
- Current Assignee: VGX Pharmaceuticals, Inc.
- Current Assignee Address: US PA Blue Bell
- Agent Thomas Kim
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A01N63/00 ; A01N65/00
Abstract:
The present invention pertains to compositions and methods useful for treating anemia and other effects that are commonly associated in cancer bearing animals. The invention is accomplished by delivering an effective amount of a nucleic acid expression construct that encodes a GHRH or functional biological equivalent thereof into a tissue of an animal and allowing expression of the encoded gene in the animal.
Public/Granted literature
- US20090170748A1 Plasmid mediated supplementation for treating chronically ill subjects Public/Granted day:2009-07-02
Information query
